Patents Assigned to Nanocarrier Kabushiki Kaisha
  • Publication number: 20140142167
    Abstract: Micellar preparation in which the solubility of a sparingly water-soluble anticancer agent has been heightened and which after intravenous administration, enables a high blood concentration to be maintained. The preparation has high medicinal activity and/or reduced side effects, and is formed from a block copolymer represented by formula (1): [wherein R1 represents hydrogen or C1-5 alkyl; R2 represents C1-5 alkylene; R3 represents methylene or ethylene; R4 represents hydrogen or C1-4 acyl; R5 represents hydroxyl, optionally substituted aryl C2-8 alkoxyl, substituted C1-4 alkylamino, or amino having a residue of either an amino acid or a peptide derivative; n is an integer of 5 to 1,000; m is an integer of 2 to 300; and x is an integer of 1 to 300; provided that the proportion of hydroxy in the R5's is 0 to 99% and x is not larger than m] and a sparingly water-soluble anticancer agent.
    Type: Application
    Filed: December 17, 2013
    Publication date: May 22, 2014
    Applicants: Nanocarrier Kabushiki Kaisha, Nippon Kayaku Kabushiki Kaisha
    Inventors: Kazuhisa Shimizu, Toshitaka Murata, Katsuhiko Sagawa
  • Patent number: 7820759
    Abstract: A novel micellar preparation in which the solubility of a sparingly water-soluble anticancer agent has been heightened and which after intravenous administration, enables a high blood concentration to be maintained. The preparation has high medicinal activity and/or is reduced in side effects. The micellar preparation is formed from a block copolymer represented by the following general formula (1): [wherein R1 represents hydrogen or C1-5 alkyl; R2 represents C1-5 alkylene; R3 represents methylene or ethylene; R4 represents hydrogen or C1-4 acyl; R5 represents hydroxyl, optionally substituted aryl C2-8 alkoxyl, substituted C1-4 alkylamino, or amino having a residue of either an amino acid or a peptide derivative; n is an integer of 5 to 1,000; m is an integer of 2 to 300; and x is an integer of 1 to 300; provided that the proportion of hydroxy in the R5's is 0 to 99% and x is not larger than m] and a sparingly water-soluble anticancer agent.
    Type: Grant
    Filed: January 30, 2009
    Date of Patent: October 26, 2010
    Assignees: Nippon Kayaku Kabushiki Kaisha, Nanocarrier Kabushiki Kaisha
    Inventors: Kazuhisa Shimizu, Toshitaka Murata, Katsuhiko Sagawa
  • Publication number: 20060110356
    Abstract: The current situation is such that it is difficult for drugs to reach posterior tissues of an eyeball, such as choroid and retina, with the result that treating diseases in such regions is difficult. Thus, how to attain effective delivery of drugs is of importance. It has been found that effective delivery of drugs to positerior tissues of the eyeball, such as choroid and retina, especially those wherein vascularization has occurred can be accomplished by systemic administration, especially intravenous administration of polymer micells having a drug incorporated therein. Further, it has been found that when a photosensitive substance is used as a drug and PDT is carried out, choroidal neo-vessels can be effectively choked so as to be useful for the treatment of age-related macular degeneration.
    Type: Application
    Filed: October 14, 2005
    Publication date: May 25, 2006
    Applicant: NANOCARRIER KABUSHIKI KAISHA
    Inventors: Kazunori Kataoka, Yasuhiro Tamaki, Atsushi Harada, Fumitaka Tasaka